Units Plummets After Novo Nordisk Deal Collapse
Shares of HIMS experienced a dramatic slump today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate